Get updates delivered to you daily. Free and customizable.
Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
By Lisa Levin,
Jounce Therapeutics, Inc. (NASDAQ: JNCE ) shares rose 36.8% to $1.45 in pre-market after the company confirmed receipt of unsolicited proposal from Concentra Biosciences to acquire 100% of the company for $1.80 per share subject to diligence and availability of at least $130m of cash and equivalents at closing.
HUB Cyber Security (Israel) Ltd. (NASDAQ: HUBC ) rose 15.5% to $1.93 in pre-market trading after gaining more than 10% on Tuesday. HUB Security received $4 million from PIPE Investors at $10 per share.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC ) rose 15.2% to $1.81 in pre-market trading after gaining around 5% on Tuesday.
TC Biopharm (Holdings) Plc (NASDAQ: TCBP ) rose 14.1% to $3.49 in pre-market trading.
Loyalty Ventures Inc. (NASDAQ: LYLT ) rose 13.2% to $0.1924 in pre-market trading after dipping 23% on Tuesday.
Smartsheet Inc. (NYSE: SMAR ) rose 11.2% to $42.61 in pre-market trading after the company reported better-than-expected Q4 results and issued strong EPS guidance.
Ambipar Emergency Response (NYSE: AMBI ) rose 10.5% to $13.54 in pre-market trading after jumping around 117% on Tuesday.
Elevation Oncology, Inc. (NASDAQ: ELEV ) rose 9.8% to $1.57 in pre-market trading after jumping around 29% on Tuesday.
Kingsoft Cloud Holdings Limited (NASDAQ: KC ) rose 8.6% to $4.43 in pre-market trading.
Inpixon (NASDAQ: INPX ) fell 41.9% to $0.41 in pre-market. Inpixon completed distribution and business combination of CXApp Holding Corp. with KINS Technology Group Inc.
Boxed, Inc. (NYSE: BOXD ) fell 38.8% to $0.26 in pre-market trading. Boxed is negotiating with lenders for bankruptcy sale, the Wall Street Journal reported.
Celyad Oncology SA (NASDAQ: CYAD ) shares fell 25.1% to $0.7199 in pre-market trading. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.
Credit Suisse Group AG (NYSE: CS ) fell 22.3% to $1.95 in pre-market trading. Saudi Arabia's SNB said it cannot give more money to Credit Suisse because cannot go above 10% ownership due to regulatory issue.
Intelligent Bio Solutions Inc. (NASDAQ: INBS ) fell 19.5% to $2.21 in pre-market trading. Intelligent Bio Solutions recently announced pricing of a $2.2 million public offering.
Vacasa, Inc. (NASDAQ: VCSA ) fell 13.7% to $1.13 in pre-market trading after reporting Q4 results.
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX ) fell 12.1% to $0.4607 in pre-market trading. Quoin Pharmaceuticals recently posted a Q4 loss of $0.41 per share.
Elys Game Technology, Corp. (NASDAQ: ELYS ) shares dropped 10.5% to $0.51 in pre-market trading after surging 33% on Tuesday.
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) fell 10.3% to $10.50 in pre-market trading. Merrimack Pharmaceuticals recently posted a FY22 loss of $0.11 per share.
Lannett Company, Inc. (NYSE: LCI ) shares fell 10.1% to $1.60 in pre-market trading after declining over 4% on Tuesday. Lannett recently posted upbeat Q2 results.